Policy

Is it legal to buy peptides in the US?

The law mostly looks at who is selling and how. Here is where a prescription, a compounding pharmacy, a "research use only" vial and an overseas order each stand.

10 November 2026 5 min read By Peptide AI Editorial policy

Yes, it is legal to buy a peptide in the US when it is an FDA-approved medicine, or a preparation compounded by a licensed pharmacy from an eligible ingredient, dispensed on a prescription. A peptide sold online as "research use only" is not an approved drug, and FDA says importing unapproved drugs for personal use is illegal in most circumstances. The law does not treat "peptides" as one thing. It treats each product by how it is made and how it is sold, so the same molecule can be a legal prescription from one source and an unapproved drug from another. This page sets out the channels, what FDA has said about each, and what that means for someone buying. It is general information, not legal advice, and it covers the United States only.

The short version

  • By prescription, from a pharmacy. Legal. This covers FDA-approved peptide medicines and preparations compounded by a licensed pharmacy from an eligible ingredient.
  • Sold online as "research use only." Not an approved drug. FDA's position is that selling it for human use breaks federal law, and its enforcement has gone to sellers.
  • Imported from overseas for yourself. FDA says importing unapproved drugs for personal use is illegal in most circumstances.
  • State, workplace and sport rules. Separate from all of the above, and sometimes stricter.

Four channels, four answers

ChannelWhat it isWhere it stands
FDA-approved medicineA product FDA has approved for a stated use, made under current good manufacturing practice. Semaglutide, tirzepatide, tesamorelin and bremelanotide are examples.Legal with a prescription.
503A compounded preparationMade by a licensed pharmacy for one patient, on a prescription, from a bulk substance that is a component of an approved drug, has a USP monograph, or is on FDA's 503A bulks list.Legal when the ingredient is eligible. Many popular peptides are not eligible today.
"Research use only" productSold as a laboratory reagent, labelled "not for human consumption." Not approved, not made under drug manufacturing rules.FDA treats it as an unapproved new drug when the seller markets it for people. The label does not change that.
Personal importOrdered from a seller outside the US and shipped to you.Illegal in most circumstances, according to FDA. Shipments can be refused or detained.

Are "research use only" peptides legal?

The phrase describes the terms of a sale. It says the seller is offering a reagent, not a medicine. It is not a finding by any regulator that the product is safe, pure or legal to use on yourself. Our research chemical glossary entry goes through what the label is doing.

FDA has said repeatedly that the label does not decide what a product is. The agency looks at how it is sold. In its warning letter of 24 August 2026 to one online seller, FDA wrote that "despite statements on your product labeling", "evidence obtained from your website establishes that your products are intended to be drugs for human use." The same letter counted bacteriostatic water sold alongside the vials as part of the evidence. Our enforcement page lists the letters we have verified, back to December 2024.

Two things follow for a buyer. First, every letter on that list is addressed to a seller. We have not found one addressed to an individual who bought for personal use. That describes enforcement so far. It is not a promise about the future and it is not a legal protection. Second, the legal exposure is not the main risk in this channel. A product outside drug regulation has no one checking what is in the vial, which is the subject of our page on sourcing, purity and testing.

Which peptides a pharmacy can compound

A prescription does not make every peptide available. A 503A pharmacy can only compound from an eligible bulk substance, and FDA decides which substances are eligible. In April 2026 a group of peptides came off FDA's Category 2 list, where pharmacies were expected not to compound them, after their nominations were withdrawn. That did not make them eligible for compounding. FDA then put several of them in front of its Pharmacy Compounding Advisory Committee. In July 2026 the committee voted to recommend several of them, including BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax. A recommendation is not a rule. At our last check, on 15 October 2026, FDA had not issued one.

The Category 2 page tracks each peptide's status, and the 503A list page explains the process. If a clinic offers to prescribe a compounded peptide, the question to ask is which of the three eligibility routes the ingredient comes through. Our four checks for a peptide clinic cover the rest.

Importing for personal use

FDA's guidance on personal importation says that in most circumstances it is illegal for individuals to import drugs into the United States for personal use, because products bought abroad are often not FDA-approved. The agency describes situations where its staff may decide not to stop a shipment. That is discretion on FDA's side. It does not make the import legal, and a package can still be refused at the border.

State, sport and substance-specific rules

  • States. States license pharmacies, prescribers and clinics, and some have acted on peptides directly. Ohio's Board of Pharmacy has said "research purposes only" drugs are "unlawful to possess by prescriber clinics and med spas." Louisiana wrote peptide compounding into state law in 2026. See state peptide laws.
  • Sport. A peptide can be legal to possess and still banned in competition. See WADA and peptides.
  • Specific substances. A few hormones have their own federal rules that go beyond the general drug law. Human growth hormone is the best known. Check the rule for the specific substance, not for "peptides" in general.

What the law does not settle

Legal and well made are different questions. A prescription from a licensed pharmacy answers both, because the pharmacy is responsible for the product. Anything bought outside that system leaves quality to the buyer: whether the vial holds the peptide on the label, how much, and what else is in it. Published testing of products bought online has found label claims and measured content often diverge.

That gap is what we are working on. Peptide AI is building a marketplace with two ways to buy: on a prescription through licensed telehealth, for what can legally be prescribed, or from vetted suppliers with an independent lab report you read before you order. It is not open yet. Buy peptides with the lab report first.

Questions people ask

Is it legal to buy peptides online in the US?

It depends on the channel. A peptide medicine dispensed on a prescription, either FDA-approved or compounded by a licensed pharmacy from an eligible ingredient, is legal. A product sold online as research use only is not an approved drug, and FDA treats it as an unapproved new drug when the seller markets it for people.

Can I get in trouble for buying research peptides?

The FDA warning letters we track are all addressed to sellers, not to individual buyers. That is a description of enforcement so far, not a legal safe harbour. State rules, import rules and sport rules can still apply to you.

Does a research use only label make a peptide legal to sell?

No. FDA has said in warning letters since at least December 2024 that the label does not decide what a product is. The agency looks at how the product is marketed.

Is it legal to import peptides for personal use?

FDA says that in most circumstances it is illegal for individuals to import unapproved drugs for personal use. Its personal importation policy describes when staff may use discretion. It is not a right to import.

Which peptides can a pharmacy compound with a prescription?

Only those made from a bulk substance that is a component of an approved drug, has a USP monograph, or is on FDA's 503A bulks list. Several popular peptides were recommended by FDA's advisory committee in July 2026, but at our last check FDA had not issued a rule adding them.

Sources

  1. Warning letter 735127 to an online peptide seller, U.S. Food and Drug Administration, 24 August 2026
  2. Bulk drug substances used in compounding under section 503A of the FD&C Act, U.S. Food and Drug Administration
  3. Certain bulk drug substances for use in compounding that may present significant safety risks, U.S. Food and Drug Administration, content current as of 22 April 2026
  4. July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee, U.S. Food and Drug Administration
  5. Personal importation, U.S. Food and Drug Administration
  6. Compounding and the FDA: questions and answers, U.S. Food and Drug Administration
Free on iOS and Android

Log it once. See it all on one timeline.

Doses, food, training, labs, sleep and scans on one timeline. On iOS and Android.

The PeptideAI protocol screen with a weekly GLP-1 dose on it.